Healthcare provider profile · identity verified

Mark Lloyd, D.O.

Family Practice · LEWISBURG, PA · NPI 1407076458

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1015	269
Lisinopril	Lisinopril	463	122
Omeprazole	Omeprazole	404	112
Amlodipine Besylate	Amlodipine Besylate	394	116
Levothyroxine Sodium	Levothyroxine Sodium	364	87
Losartan Potassium	Losartan Potassium	302	85
Rosuvastatin Calcium	Rosuvastatin Calcium	300	90
Metoprolol Succinate	Metoprolol Succinate	276	78
Metformin Hcl Er	Metformin Hcl	255	69
Gabapentin	Gabapentin	242	62
Tamsulosin Hcl	Tamsulosin Hcl	212	57
Sertraline Hcl	Sertraline Hcl	203	55
Eliquis	Apixaban	195	45
Furosemide	Furosemide	181	47
Fluticasone Propionate	Fluticasone Propionate	161	50
Metoprolol Tartrate	Metoprolol Tartrate	155	43
Clopidogrel	Clopidogrel Bisulfate	134	36
Ozempic	Semaglutide	132	28
Famotidine	Famotidine	125	39
Duloxetine Hcl	Duloxetine Hcl	118	24
Pantoprazole Sodium	Pantoprazole Sodium	114	36
Jardiance	Empagliflozin	107	31
Trazodone Hcl	Trazodone Hcl	107	26
Ezetimibe	Ezetimibe	106	33
Warfarin Sodium	Warfarin Sodium	106	29
Enalapril Maleate	Enalapril Maleate	98	27
Finasteride	Finasteride	97	27
Allopurinol	Allopurinol	94	25
Montelukast Sodium	Montelukast Sodium	92	24
Hydrochlorothiazide	Hydrochlorothiazide	88	29
Metformin Hcl	Metformin Hcl	85	25
Albuterol Sulfate Hfa	Albuterol Sulfate	83	34
Atenolol	Atenolol	80	26
Escitalopram Oxalate	Escitalopram Oxalate	79	17
Carvedilol	Carvedilol	77	22
Pregabalin	Pregabalin	66	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	66	17
Potassium Chloride	Potassium Chloride	63	15
Donepezil Hcl	Donepezil Hcl	58	12
Doxazosin Mesylate	Doxazosin Mesylate	57	16
Arexvy	Rsvpref3 Antigen/As01e/Pf	54	54
Oxycodone Hcl	Oxycodone Hcl	54	16
Baclofen	Baclofen	51	16
Alendronate Sodium	Alendronate Sodium	49	22
Diclofenac Sodium	Diclofenac Sodium	49	20
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	45	12
Spironolactone	Spironolactone	43	suppressed
Trulicity	Dulaglutide	43	suppressed
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Torsemide	Torsemide	40	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	38	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Simvastatin	Simvastatin	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	11
Prednisone	Prednisone	33	30
Sumatriptan Succinate	Sumatriptan Succinate	33	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Valsartan	Valsartan	33	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Bupropion Hcl Sr	Bupropion Hcl	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Nitroglycerin	Nitroglycerin	30	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Lorazepam	Lorazepam	29	suppressed
Meloxicam	Meloxicam	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Glipizide Er	Glipizide	28	11
Tramadol Hcl	Tramadol Hcl	27	suppressed
Glipizide	Glipizide	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Klor-Con M20	Potassium Chloride	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Tradjenta	Linagliptin	24	suppressed
Novolog Flexpen	Insulin Aspart	23	suppressed
Risperidone	Risperidone	23	suppressed
Fentanyl	Fentanyl	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	11
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Amoxicillin	Amoxicillin	19	12
Lamotrigine	Lamotrigine	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Repaglinide	Repaglinide	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Levoxyl	Levothyroxine Sodium	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Felodipine Er	Felodipine	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Jantoven	Warfarin Sodium	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Cephalexin	Cephalexin	15	15
Colestipol Hcl	Colestipol Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	13
Varenicline Tartrate	Varenicline Tartrate	15	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Colchicine	Colchicine	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Metolazone	Metolazone	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Victoza 3-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error